Suchergebnisse - "Telci, Dilek"

PubPharm (90)

51

Poloxamer P85 increases anticancer activity of Schiff base against prostate cancer in vitro and in vivo

enthalten in: Anti-cancer drugs | 2017

von Demirci, S. | Doğan, A. | Başak Türkmen, N. | +7

52

Sambulin A and B, non-glycosidic iridoids from Sambucus ebulus, exert significant in vitro anti-inflammatory activity in LPS-induced RAW 264.7 macrophages via inhibition of MAPKs's phosphorylation

enthalten in: Journal of ethnopharmacology | 2017

von Balkan, �. | İlter Akülke, A. | Bağatur, Y. | +4

53

Schiff base-Poloxamer P85 combination demonstrates chemotherapeutic effect on prostate cancer cells in vitro

enthalten in: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie | 2017

von Demirci, S. | Doğan, A. | Türkmen, N. | +3

54

Poloxamer P85 increases anticancer activity of Schiff base against prostate cancer in vitro and in vivo

enthalten in: Anti-cancer drugs | 2017

von Demirci, S. | Doğan, A. | Başak Türkmen, N. | +7

55

Schiff Base-Poloxamer P85 Combination Prevents Prostate Cancer Progression in C57/Bl6 Mice

enthalten in: The Prostate | 2016

von Doğan, A. | Demirci, S. | Türkmen, N. | +9

56

Schiff Base‐Poloxamer P85 Combination Prevents Prostate Cancer Progression in C57/Bl6 Mice

enthalten in: The prostate | 2016

von Doğan, A. | Demirci, S. | Türkmen, N. | +9

57

The increased transglutaminase 2 expression levels during initial tumorigenesis predict increased risk of metastasis and decreased disease-free and cancer-specific survivals in renal cell carcinoma

enthalten in: World journal of urology | 2015

von Erdem, S. | Yegen, G. | Telci, D. | +5

58

A Schiff base derivative for effective treatment of diethylnitrosamine-induced liver cancer in vivo

enthalten in: Anti-cancer drugs | 2015

von Demirci, S. | Doğan, A. | Başak, N. | +8

59

A Schiff base derivative for effective treatment of diethylnitrosamine-induced liver cancer in vivo

enthalten in: Anti-cancer drugs | 2015

von Demirci, S. | Doğan, A. | Başak, N. | +8

60

The increased transglutaminase 2 expression levels during initial tumorigenesis predict increased risk of metastasis and decreased disease-free and cancer-specific survivals in renal cell carcinoma

enthalten in: World journal of urology | 2014

von Erdem, S. | Yegen, G. | Telci, D. | +5